Adiponectin and breast cancer.

Medical Oncology
Xiuping Chen, Yitao Wang

Abstract

Adiponectin, an adipose tissue-derived hormone, has been studied intensively for the past decade because of its anti-inflammatory, anti-atherogenic, and anti-diabetic properties. Recent advances suggest that adiponectin also plays an important role in the development and progression of various cancers, especially obesity-related cancers. In this review, the authors focus on the potential role of adiponectin in breast cancer, an obesity- and endocrine-associated tumor. Epidemiological studies have shown that plasma adiponectin level is a risk factor for breast cancer in post-menopausal women. Adiponectin and its receptors are expressed on both breast cancer line cells and tumor tissues. Furthermore, exogenous adiponectin has exhibited therapeutic potential in animal models. Underlying mechanisms include the inhibition of cell proliferation and promotion of apoptosis, the regulation of tumorigenic-related factors, and the suppression of angiogenesis. The signaling pathways linking adiponectin with tumorigenesis might provide potential drug targets for the future. However, more convincing evidence is needed to fully elucidate the exact role of adiponectin in breast cancer, since both its beneficial effects and possible mechanisms ...Continue Reading

References

Jun 13, 2003·Nature·Toshimasa YamauchiTakashi Kadowaki
Nov 7, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y MiyoshiS Noguchi
Feb 10, 2004·Biochemical and Biophysical Research Communications·Hiroyuki MotoshimaBarry J Goldstein
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ebba BråkenhielmYihai Cao
Mar 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Christos MantzorosDimitrios Trichopoulos
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Christopher HugHarvey F Lodish
Jul 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Takayuki MasakiHironobu Yoshimatsu
Jan 5, 2005·Biochemical and Biophysical Research Communications·Kun-yong KimYoung Yang
May 18, 2005·Endocrine Reviews·Takashi Kadowaki, Toshimasa Yamauchi
Jun 7, 2005·Biochemical and Biophysical Research Communications·Toshiaki MiyazakiYoshiki Iwamoto
Jul 16, 2005·Cancer Letters·Da-Chung ChenShyng-Shou F Yuan
Dec 15, 2005·Archives of Pharmacal Research·Jee Hyun KangYong Kyun Roh
Mar 30, 2006·British Journal of Cancer·I KelesidisC S Mantzoros
May 9, 2006·Biochemical and Biophysical Research Communications·Marie-Noelle DieudonneRené Pecquery
Jul 11, 2006·The Journal of Clinical Investigation·Takashi KadowakiKazuyuki Tobe
Jul 25, 2006·Expert Opinion on Investigational Drugs·Diana BarbChristos S Mantzoros
Aug 26, 2006·Cytokine & Growth Factor Reviews·A NicoliniG Rossi
Nov 25, 2006·Cancer Letters·Chie TakahataShinzaburo Noguchi
Dec 16, 2006·Mini Reviews in Medicinal Chemistry·Xuming MaoLily Q Dong
Dec 29, 2006·The Journal of Clinical Endocrinology and Metabolism·Antje KörnerChristos S Mantzoros
Jan 11, 2007·The Journal of Clinical Endocrinology and Metabolism·Shelley S TworogerSusan E Hankinson
Jan 18, 2007·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J D ArditiG P Chrousos
Feb 14, 2007·Journal of Korean Medical Science·Jee-Hyun KangDae-Sung Youn
Apr 21, 2007·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J HectorP Algenstaedt
Aug 2, 2007·Menopause : the Journal of the North American Menopause Society·Soon Cheol HongSun Haeng Kim
Oct 5, 2007·Endocrine-related Cancer·Yu-Feng TianChien-An Sun
Oct 6, 2007·Medical Oncology·Mehmet KaradumanMelih Alomeroglu
Jan 10, 2008·British Journal of Cancer·M E GrossmannM P Cleary
Feb 13, 2008·The American Journal of Clinical Nutrition·Diana BarbChristos S Mantzoros
Mar 4, 2008·Molecular and Cellular Endocrinology·Olorunseun O Ogunwobi, Ian L P Beales
Mar 8, 2008·Fertility and Sterility·Nektarios ChalvatzasIoannis E Messinis
Mar 14, 2008·Cardiovascular & Hematological Disorders Drug Targets·Jerzy BełtowskiSylwia Widomska
Mar 19, 2008·Menopause : the Journal of the North American Menopause Society·Yuka MiyataniMinoru Irahara
Apr 17, 2008·The Proceedings of the Nutrition Society·Tobias PischonHeiner Boeing
May 3, 2008·Cancer Research·Virginia G KaklamaniChristos Mantzoros

❮ Previous
Next ❯

Citations

Oct 19, 2013·Journal of Mammary Gland Biology and Neoplasia·Eva Surmacz
Jan 24, 2013·Cancer Prevention Research·Kristin L CampbellCornelia M Ulrich
Aug 31, 2013·PloS One·Li-Yuan LiuZhi-Gang Yu
Feb 6, 2013·World Journal of Gastroenterology : WJG·Mansour A Parsi
Feb 8, 2014·Cancer Causes & Control : CCC·Laure DossusSylvie Mesrine
Jun 13, 2013·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Michela Garofalo, Carlo M Croce
Aug 23, 2012·Cytokine & Growth Factor Reviews·Xiuping ChenYitao Wang
Dec 20, 2015·Cytokine·Ding LiuZhihong Li
Nov 30, 2012·Journal of Cellular Biochemistry·Xiuping Chen
Oct 24, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Machiko MinatoyaKoichi Hirata
Nov 12, 2013·Cytokine & Growth Factor Reviews·Sajid KhanSyed Musthapa Meeran
Jan 1, 2015·Chemico-biological Interactions·Natalia I KrupenkoSergey A Krupenko
May 28, 2019·International Journal of Molecular Sciences·Sheetal ParidaDipali Sharma
Apr 17, 2014·International Journal of Epidemiology·Debora MacisSara Gandini
Feb 7, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Loredana MauroSebastiano Andò
Mar 7, 2020·Frontiers in Endocrinology·Giuseppina Daniela NaimoSebastiano Andò
Apr 13, 2021·Frontiers in Oncology·Shuwen DongXiaosong Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.